INTELLIA THERAPEUTICS, INC. (NTLA) Operating income 2016–2025
INTELLIA THERAPEUTICS, INC. (NTLA) annual operating income history from SEC filings — each fiscal year as reported.
-$441.0MFY2025 · since FY2016: -$32.2M → -$441.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$441.0M | +17.5% |
| FY2024 | -$534.3M | -3.7% |
| FY2023 | -$515.3M | -12.5% |
| FY2022 | -$458.2M | -71.1% |
| FY2021 | -$267.9M | -96.1% |
| FY2020 | -$136.6M | -28.4% |
| FY2019 | -$106.4M | -17.1% |
| FY2018 | -$90.9M | -30.6% |
| FY2017 | -$69.6M | -116.3% |
| FY2016 | -$32.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice